OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
January 02, 2012
Pressure to approve new user fees opens the door to action on drug shortages, prices, and regulation.
December 02, 2011
Added responsibilities and outside concerns prompt overhaul of agency's structure.
November 02, 2011
Clamor mounts over compromised care and rising costs due to lack of crucial therapies.
October 02, 2011
Manufacturers fund research and reduce prices to tackle diseases.
September 02, 2011
PDUFA renewal legislation sets stage for new policies affecting revenue, resarch, and oversight.
August 02, 2011
Rising imports and overseas production spur realignment of enforcement.